[Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa]. 1971

F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri

UI MeSH Term Description Entries
D007361 Intelligence Tests Standardized tests that measure the present general ability or aptitude for intellectual performance. Mental Tests,Raven Test,Raven's Progressive Matrices,Intelligence Test,Mental Test,Raven Progressive Matrices,Ravens Progressive Matrices,Test, Intelligence,Test, Mental,Test, Raven
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011386 Projective Techniques Techniques to reveal personality attributes by responses to relatively unstructured or ambiguous stimuli. Picture Frustration Study,Rosenzweig Picture-Frustration Study,Szondi Test,Projective Technics,Psychodynamic Assessment,Psychosomatic Assessment,Rosenzweig Picture Frustration Study,Assessment, Psychodynamic,Assessment, Psychosomatic,Assessments, Psychodynamic,Assessments, Psychosomatic,Frustration Study, Picture,Projective Technic,Projective Technique,Psychodynamic Assessments,Psychosomatic Assessments,Study, Picture Frustration,Study, Rosenzweig Picture-Frustration,Technic, Projective,Technics, Projective,Technique, Projective,Techniques, Projective,Test, Szondi
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000547 Amantadine An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. 1-Aminoadamantane,Adamantylamine,Adekin,Aman,Amanta,Amanta-HCI-AZU,Amanta-Sulfate-AZU,Amantadin AL,Amantadin AZU,Amantadin Stada,Amantadin-neuraxpharm,Amantadin-ratiopharm,Amantadina Juventus,Amantadina Llorente,Amantadine Hydrochloride,Amantadine Sulfate,Amixx,Cerebramed,Endantadine,Gen-Amantadine,Infecto-Flu,Infex,Mantadix,Midantan,PMS-Amantadine,Symadine,Symmetrel,Viregyt,Wiregyt,tregor,1 Aminoadamantane,AL, Amantadin,AZU, Amantadin,Amanta HCI AZU,Amanta Sulfate AZU,AmantaHCIAZU,AmantaSulfateAZU,Amantadin neuraxpharm,Amantadin ratiopharm,Amantadinneuraxpharm,Amantadinratiopharm,Gen Amantadine,GenAmantadine,Hydrochloride, Amantadine,Infecto Flu,InfectoFlu,Juventus, Amantadina,Llorente, Amantadina,PMS Amantadine,PMSAmantadine,Stada, Amantadin,Sulfate, Amantadine

Related Publications

F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
October 1970, Lancet (London, England),
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
June 1970, The Journal of the Florida Medical Association,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
September 1970, Lancet (London, England),
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
August 1970, Lancet (London, England),
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
May 1972, Bollettino della Societa italiana di biologia sperimentale,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
August 1970, Drug and therapeutics bulletin,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
August 1972, Australian and New Zealand journal of medicine,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
November 1969, Wisconsin medical journal,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
June 1973, Journal of neurology, neurosurgery, and psychiatry,
F M Puca, and V Micalizzi, and G F Megna, and N F Barbieri, and M T Pigneri
October 1971, Minerva medica,
Copied contents to your clipboard!